Strategy to reduce side effects in modern cancer therapy
Saturday, September 27, 2014 - 05:31
in Health & Medicine
A new strategy for reducing the often serious side effects of an important class of modern anticancer drugs -- tyrosine kinase inhibitors has been developed by an international team of researchers. The novel drug is supposed to restrict its activity with high selectivity to the malignant tumor.